openPR Logo
Press release

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape | Now Available at Researchmoz.us

10-19-2016 11:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Rmoz Global Pvt. Ltd.

Researchmoz added Most up-to-date research on "Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape" to its huge collection of research reports.

Latest report, ""Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus on the technological, competitive and R&D landscape. Along extensive secondary research efforts, GBI research conducted a targeted industry survey of experts and key opinion leaders in the stem cell therapies field to gather opinions on the global trends and future commercial prospects of the stem cell therapies market. The findings from the reviewed literature were measured against the results of the industry survey, and internal research, to provide an objective view of the market that is comprehensive in outlook.

Stem cell therapies are one of the largest segments of the regenerative medicine market, even when non-therapeutic applications of stem cells are excluded. This rapidly growing sector offers a number of opportunities to both biotechnology and pharmaceutical companies seeking to diversify away from traditional pharmacological compositions and towards a more therapeutic approach, similar to the successful arrival of targeted biologic therapies before the turn of the century. Stem cell therapy represents a very promising platform for clinical advancements in areas where current pharmacological and surgical treatment options are not effective.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=760965

These therapies have been in development for human therapeutic use for many decades and there has been steady progress in clinical research, with a few products having already entered the market. Moreover, information leveraged from our robust industry-leading database shows a diverse range of stem cell therapies currently in development for a wide range of indications, with some of these progressing to the later stages of clinical development. Over 15 therapy areas are being targeted by the stem cell industry in over 1,000 clinical trials, our study shows. Our new report provides multilevel analysis of the R&D landscape including data split by therapy area, stage of development, company and many other insightful and pertinent analytics.

Converting the scientific potential of stem cell technology into real therapeutic value still represents a significant challenge, however. The stem cells field is still surrounded by a wide variety of scientific, technological, legal and ethical challenges, and suitability for commercial usage has been rather slow to attain. If stem cell therapies are to realize their full commercial potential manufacturers will need to adopt novel and comprehensive strategies to overcome these challenges, such as those described in this report.

Results from our secondary research efforts and proprietary industry survey have been integrated and triangulated with our own analytical views to create a cohesive, insightful and objective assessment, examining the current state of the stem cell therapies market and its future commercial prospects. This new CBR report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the life sciences industry and exploit key business opportunities.

Scope

- What are the most pertinent commercial trends in the stem cell therapies market?
- What have been the key milestones in stem cell research since the 1900s?
- What can be learned from the stem cell therapies that have already reached the market?
- What are the most important factors contributing to growth in the stem cell therapy market?
- What are the most important factors restraining stem cell therapy market growth?
- What are the most important factors that have had a negative impact on funding and investment for stem cell research?
- Which therapeutic areas have the largest volume of stem cell therapies in development?
- Which therapeutic areas will see the highest number of stem cell therapies commercialized over the next decade?
- What will be the most commercially viable types of adult stem cells over the next decade?
- What are the most important manufacturing challenges in the process of developing cell therapies from stem cells?
- How important is overcoming ethical issues to the commercial success of stem cell therapies?
- What are the most important ethical challenges in the stem cell therapy market?
- What are the most recent advances in stem cell manufacturing technology and what type of manufacturing strategies should manufacturers adopt?
- What are the main therapy areas of interest for companies involved in stem cell therapy R&D?

- Gain insightful analyses and understanding of market dynamics. This report comprehensively describes and assesses the most pertinent commercial, technological, and innovative aspects of the stem cell therapy market. Obtain an analytical review of the most important factors driving or restraining growth in the stem cell therapy market through our industry survey results, examining the relative importance of these factors. Specific challenges to successful stem cell therapy development and commercialization are therefore explored in detail and the most important drivers of growth, and opportunities in the field, are identified and discussed.

- Assess the stem cells marketed products landscape. Our new study provides an overview of the marketed products landscape in the stem cell therapies market, including product profiles of key marketed products worldwide. Explore the level of commercial viability of different types of adult stem cells over the next decade, through our industry survey results and literature reviews.
- Assess global trends in the stem cells R&D landscape. Examine the pipeline for stem cell therapies split by therapy area and stage of development. A granular assessment of the pipeline is provided across the four major therapy areas for stem cell therapy: immunology, cardiovascular disorders, central nervous system disorders and oncology. Furthermore, our industry survey provides insights on the therapeutic areas with the greatest commercial prospects.
- Understand current stem cell production strategies, challenges and recent technological advances. The report outlines common processes and key elements in stem cell production. These obstacles in manufacturing are reviewed against results of our industry survey examining the relative importance of the main challenges in the process of developing cell therapies from stem cells.
- Assess competition in the stem cell therapies market. Gain a picture of the current competitive landscape, with a detailed breakdown of companies actively involved in the stem cell therapies pipeline. Understand the level of involvement on the part of big pharma companies and other research institutions, and the extent to which stem cell therapies fit into the overall portfolios of companies this field. Additionally, a highly granular breakdown of companies developing multiple stem cell therapies is provided.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=760965

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape | Now Available at Researchmoz.us here

News-ID: 373999 • Views:

More Releases from Rmoz Global Pvt. Ltd.

Inhaled Corticosteroids (ICS), Long-Acting Beta2-Agonists (LABA), Antihistamines …
"Pulmonary Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Pulmonary Drugs Market: Snapshot This report on pulmonary drugs studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs
Merck & Co., Inc., Zoetis Services Llc, Bayer Ag, Elanco, Merial, Boehringer Ing …
"Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor
GlaxoSmithKline plc, F. Hoffmann-La Roche, AstraZeneca plc, Novartis AG, Boehrin …
"Asthma and COPD Drugs Market - U.S. and China Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- U.S. and China Asthma and COPD Drugs Market: Overview Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is
ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin, and besiflox …
"Bacterial Conjunctivitis Drugs Market - U.S. Industry Analysis, Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2012 - 2024" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and

All 5 Releases


More Releases for R&D

Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow